These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation? Schmidt B; Chun KR; Baensch D; Antz M; Koektuerk B; Tilz RR; Metzner A; Ouyang F; Kuck KH Heart Rhythm; 2010 Dec; 7(12):1746-52. PubMed ID: 20709191 [TBL] [Abstract][Full Text] [Related]
12. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease. Izquierdo M; Sánchez-Gómez JM; Ferrero de Loma-Osorio A; Martínez A; Bellver A; Peláez A; Núñez J; Núñez C; Chorro J; Ruiz-Granell R Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):882-9. PubMed ID: 26056239 [TBL] [Abstract][Full Text] [Related]
13. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy. Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Sacher F; Reichlin T; Zado ES; Field ME; Viles-Gonzalez JF; Peichl P; Ellenbogen KA; Maury P; Dukkipati SR; Picard F; Kautzner J; Barandon L; Koneru JN; Ritter P; Mahida S; Calderon J; Derval N; Denis A; Cochet H; Shepard RK; Corre J; Coffey JO; Garcia F; Hocini M; Tedrow U; Haissaguerre M; d'Avila A; Stevenson WG; Marchlinski FE; Jais P Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):592-7. PubMed ID: 25870335 [TBL] [Abstract][Full Text] [Related]
15. Robotic catheter ablation of left ventricular tachycardia: initial experience. Valderrábano M; Dave AS; Báez-Escudero JL; Rami T Heart Rhythm; 2011 Dec; 8(12):1837-46. PubMed ID: 21802391 [TBL] [Abstract][Full Text] [Related]
16. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. Grinstein J; Garan AR; Oesterle A; Fried J; Imamura T; Mai X; Kalantari S; Sayer G; Kim GH; Sarswat N; Raikhelkar J; Adatya S; Jeevanandam V; Flatley E; Moss J; Uriel N ASAIO J; 2020; 66(10):1127-1136. PubMed ID: 33136600 [TBL] [Abstract][Full Text] [Related]
17. Ventricular tachycardia arising from the aortomitral continuity in structural heart disease: characteristics and therapeutic considerations for an anatomically challenging area of origin. Steven D; Roberts-Thomson KC; Seiler J; Inada K; Tedrow UB; Mitchell RN; Sobieszczyk PS; Eisenhauer AC; Couper GS; Stevenson WG Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):660-6. PubMed ID: 20009078 [TBL] [Abstract][Full Text] [Related]
18. Conversion to Purkinje-Related Monomorphic Ventricular Tachycardia After Ablation of Ventricular Fibrillation in Ischemic Heart Disease. Masuda K; Nogami A; Kuroki K; Igarashi M; Sekiguchi Y; Komatsu Y; Kowase S; Kurosaki K; Nishihara S; Niwa K; Tsuchiya T; Igawa M; Aonuma K Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635070 [TBL] [Abstract][Full Text] [Related]
19. Safety and Feasibility of a Minimally Fluoroscopic Approach for Ventricular Tachycardia Ablation in Patients With Structural Heart Disease: Influence of the Ventricular Tachycardia Substrate. Cano Ó; Andrés A; Osca J; Alonso P; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003706. PubMed ID: 26850881 [TBL] [Abstract][Full Text] [Related]
20. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]